Risk factors for poor COVID-19 outcomes in patients with psychiatric disorders
Author:
Funder
China Medical University Second Hospital
China Medical University Hospital
Publisher
Elsevier BV
Subject
Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology
Reference48 articles.
1. Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19;Austria;PLoS One,2021
2. Risk of SARS-CoV-2 infection, severe COVID-19 illness and COVID-19 mortality in people with pre-existing mental disorders: an umbrella review;Bertolini;BMC Psychiatry,2023
3. Emerging and experimental treatments for COVID-19 and drug interactions with psychotropic agents;Bishara;Therap. Adv. Psychopharmacol.,2020
4. Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care;Bjork Bramberg;BMC Fam. Pract.,2018
5. COVID-19 outcomes: does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of antidepressants-A scoping review;Bonnet;J. Clin. Psychopharmacol.,2022
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study;The Lancet Psychiatry;2024-09
2. Predictive Factors for Poor Outcomes Associated with COVID-19 in a Retrospective Cohort of Myasthenia Gravis Patients;Journal of Inflammation Research;2024-08
3. Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders;Frontiers in Pharmacology;2024-07-04
4. Outpatient Antipsychotic Use and Severe COVID-19: Avoiding the Impact of Age in a Real-World Data Study;International Journal of Neuropsychopharmacology;2024-04-01
5. Risk of COVID‐19 Hospitalization and Protection Associated With mRNA Vaccination Among US Adults With Psychiatric Disorders;Influenza and Other Respiratory Viruses;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3